Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zai Lab Ltd

34.00
+2.277.15%
Post-market: 34.000.00000.00%16:05 EST
Volume:1.93M
Turnover:64.31M
Market Cap:3.66B
PE:-13.09
High:34.08
Open:32.27
Low:31.56
Close:31.73
Loading ...

Company Profile

Company Name:
Zai Lab Ltd
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
1869
Office Location:
Jinchuang Plaza,Building 1, Fourth Floor,4560 Jinke Road,Pudong,Shanghai,China
Zip Code:
201210
Fax:
- -
Introduction:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Directors

Name
Position
Samantha Du
Founder, Chief Executive Officer and Chairperson of the Board
John Diekman
Lead Independent Director
Kai Xian Chen
Independent Director
Leon O. Moulder, Jr.
Independent Director
Michel Vounatsos
Independent Director
Nisa Leung
Independent Director
Peter Wirth
Independent Director
Richard B. Gaynor
Independent Director
Scott W. Morrison
Independent Director
William Lis
Independent Director

Shareholders

Name
Position
Samantha Du
Founder, Chief Executive Officer and Chairperson of the Board
Joshua Smiley
President and Chief Operating Officer
Yajing Chen
Chief Financial Officer
F. Ty Edmondson
Chief Legal Officer
Rafael G. Amado
President, Head of Global Oncology Research and Development